Govinda Bhisetti is a Principal Investigator and Head of Computational Chemistry at Biogen. Previously, he worked at Vertex Pharmaceuticals for 22 years where he led drug design efforts on several drug discovery projects. His research at Vertex led to the discovery of three FDA approved drugs: Agenerase, Lexiva and Incivek. He is a co-inventor of these drugs and named inventor on 26 patents. He has also published 75 research papers including review articles and book chapters. His current activities include application of state of the art computational methods in the discovery of novel drugs for CNS diseases. Govinda obtained his Ph.D. from Indian Institute of Science, Bangalore, India and worked as a post-doctoral fellow at Scripps Research Institute, La Jolla, CA before joining Vertex.